Preparation, characterization and in vitro cytotoxicity assay of curcumin loaded solid lipid nanoparticle in IMR32 neuroblastoma cell line

Pakistan Journal of Pharmaceutical Sciences

Volumn 27, Issue 5, 2014, Pages 1281-1285

  Rahman, Mohamed Habibur ^a   Ramanathan, Muthiah ^a   Sankar, Veintramuthu ^a  

^a PSG COLLEGE OF PHARMACY   (India)

Author keywords

Co surfactants; Curcumin; Solid lipid nanoparticle; Stearic acid; Tween 80

Indexed keywords

CURCUMIN; POLYSORBATE 80; SOLID LIPID NANOPARTICLE; STEARIC ACID; SURFACTANT; ANTINEOPLASTIC AGENT; NANOPARTICLE; STEARIC ACID DERIVATIVE;

ARTICLE; CYTOTOXICITY ASSAY; DRUG RELEASE; DRUG SOLUBILITY; DRUG STABILITY; HUMAN; HUMAN CELL; IN VITRO STUDY; MTT ASSAY; NEUROBLASTOMA CELL LINE; PARTICLE SIZE; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL; CHEMISTRY; INFRARED SPECTROSCOPY; NEUROBLASTOMA; PATHOLOGY; SOLUBILITY; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CURCUMIN; HUMANS; NANOPARTICLES; NEUROBLASTOMA; PARTICLE SIZE; SOLUBILITY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; STEARIC ACIDS;

EID: 84907818366     PISSN: 1011601X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Abbasalipourkabir R, Salehzadeh A and Abdullah R (2011). Cytotoxicity effect of solid lipid nanoparticles on human breast cancer cell lines. Biotechnology, 10: 528-533.
2. Anto RJ, Mukhopadhyay A, Denning K and Aggarwal BB (2002). Curcumin (diferuloylmethane) induces apoptosis through activation of caspase-8, BID cleavage and cytochrome c release: its suppression by ectopic expression of Bcl-2 and Bcl-xl. Carcinogenesis, 23: 143-150.
3. Begum NA, Jones RM, Lim PG, Morihara T, Kim P, Heath DD, Rock LC, Pruitt AM, Yang F, Hudspeth B, Hu S, Faull FK, Teter B, Cole MG, Sally A and Frautschy (2008). Curcumin structure-function, bioavailability and efficacy in models of neuroinflammation and Alzheimer's Disease. J. Pharmacol. Exp. Ther., 326: 196-208.
4. Burden WD (2008). Guide to the homogenization of biological samples. Random Primers, 7: 1-14.
5. Hamdani J, Moes AJ and Amighi K (2002). Development and evaluation of prolonged release pellets obtained by the melt pelletization process. Int. J. Pharm., 245: 167-177.
6. Higuchi T (1963). Mechanism of sustained action medication, J. Pharm. Sci., 52: 1145.
7. Huang MT, Lou YR, Ma W, Newmark HL, Reuhl KR and Conney AH (1994). Inhibitory effects of dietary curcumin on forestomach, duodenal and colon carcinogenesis in mice. Cancer Res., 54: 5841-5847.
8. Ireson CR (2002). Metabolism of the cancer chemopreventive agent curcumin in human and rat intestine. Cancer Epidemiol. Biomarkers Pre., 11: 105-111.
9. Korsmeyer RW, Gurny R, Docler E, Buri P and Peppas NA (1983). Mechanism of solute release from porous hydrophilic polymers. Int. J. Pharm., 15: 25.
10. Li HL, Zhao XB, Ma YK and Zhai GX (2009). Enhancement of gastrointestinal absorption of quercetin by solid lipid nanoparticles. J. Control Release, 133: 238-244.
11. Luo YF, Chen DW, Ren LX and Zhao XL (2006). Solid lipid nanoparticles for enhancing vinpocetine's oral bioavailability. J. Control Release, 114: 53-59.
12. Rahman SMH, Telny TC, Ravi TK and Kuppusamy S (2009). Role of surfactant and pH in dissolution of curcumin. Ind. J. Pharm. Sci., 71:139-142.
13. Ranajit KB, Ishita C, kaushik B and Uday B (2004). Turmeric and curcumin: Biological actions and medicinal applications. Current Science, 87: 44-53.
14. Rao CV, Rivenson A, Simi B and Reddy BS (1995). Chemoprevention of colon carcinogenesis by dietary curcumin, a naturally occurring plant phenolic compound. Cancer Res., 55: 259-266.
15. Rohit S, Mönkkönen J, Risto O, Kakasaheb R and Anant RP (2010). Transferrin mediated solid lipid nanoparticles containing curcumin: Enhanced in vitro anticancer activity by induction of apoptosis. Int. J. Pharm., 398: 190-200
16. Sargent JM (2003). The use of the MTT assay to study the drug resistance in fresh tumor samples. Recent Results Cancer Res., 161: 13-25.
17. Schwarz C and Mehnert W (1997). Freeze-drying of drug-free and drug loaded solid lipid nanoparticles. Int. J. Pharm., 157: 171-179.
18. Shaikh J, Ankola D, Beniwal DV and Singha D (2009). Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer. Eur. J. Pharm. Sci., 37: 223-230.
19. Shao ZM, Shen ZZ, Liu CH, Sartippour MR, Go VL, Heber D and Nguyen M (2002). Curcumin exerts multiple suppressive effects on human breast carcinoma cells. Int. J. Cancer, 98: 234-240.
20. Shukla Y, Arora A and Taneja P (2002). Anti-mutagenic potential of curcumin on chromosomal aberrations in Wistar rats. Mut. Res., 515: 197-202.
21. Susan B and Maryadele J (2001). The Merck index: An encyclopedia of chemicals, drugs and biologicals. Merck, Whitehouse Station, NJ. Pp. 6909.
22. Sutananta W, Craig DQ and Newton JM (1995). An investigation into the effects of preparation conditions and storage on the rate of drug release from pharmaceutical glyceride bases. J. Pharm. Pharmacol., 7: 355-359.
23. Triplett DM and Rathman FJ (2009). Optimization of β-carotene loaded solid lipid nanoparticles preparation using a high shear homogenization technique. J. Nanoparticle Research, 11: 601-614.